VERASTEM INC (VSTM) Fundamental Analysis & Valuation

NASDAQ:VSTM • US92337C2035

Current stock price

5.63 USD
+0.08 (+1.44%)
At close:
5.61 USD
-0.02 (-0.36%)
After Hours:

This VSTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VSTM Profitability Analysis

1.1 Basic Checks

  • In the past year VSTM has reported negative net income.
  • VSTM had a negative operating cash flow in the past year.
  • In the past 5 years VSTM always reported negative net income.
  • VSTM had a negative operating cash flow in each of the past 5 years.
VSTM Yearly Net Income VS EBIT VS OCF VS FCFVSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • VSTM's Return On Assets of -85.00% is on the low side compared to the rest of the industry. VSTM is outperformed by 70.79% of its industry peers.
  • VSTM's Return On Equity of -366.23% is on the low side compared to the rest of the industry. VSTM is outperformed by 74.85% of its industry peers.
Industry RankSector Rank
ROA -85%
ROE -366.23%
ROIC N/A
ROA(3y)-90.67%
ROA(5y)-83.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTM Yearly ROA, ROE, ROICVSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

  • With an excellent Gross Margin value of 82.86%, VSTM belongs to the best of the industry, outperforming 86.27% of the companies in the same industry.
  • VSTM's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for VSTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y5.71%
VSTM Yearly Profit, Operating, Gross MarginsVSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. VSTM Health Analysis

2.1 Basic Checks

  • VSTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VSTM has more shares outstanding
  • Compared to 5 years ago, VSTM has more shares outstanding
  • VSTM has a better debt/assets ratio than last year.
VSTM Yearly Shares OutstandingVSTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VSTM Yearly Total Debt VS Total AssetsVSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • VSTM has an Altman-Z score of -6.47. This is a bad value and indicates that VSTM is not financially healthy and even has some risk of bankruptcy.
  • VSTM has a Altman-Z score of -6.47. This is in the lower half of the industry: VSTM underperforms 66.15% of its industry peers.
  • VSTM has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.42, VSTM is doing worse than 77.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z -6.47
ROIC/WACCN/A
WACC9.53%
VSTM Yearly LT Debt VS Equity VS FCFVSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

2.3 Liquidity

  • A Current Ratio of 3.09 indicates that VSTM has no problem at all paying its short term obligations.
  • The Current ratio of VSTM (3.09) is worse than 62.48% of its industry peers.
  • VSTM has a Quick Ratio of 3.07. This indicates that VSTM is financially healthy and has no problem in meeting its short term obligations.
  • VSTM has a worse Quick ratio (3.07) than 60.93% of its industry peers.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 3.07
VSTM Yearly Current Assets VS Current LiabilitesVSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. VSTM Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 13.43% over the past year.
  • Looking at the last year, VSTM shows a very strong growth in Revenue. The Revenue has grown by 209.14%.
  • VSTM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -18.97% yearly.
EPS 1Y (TTM)13.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.41%
Revenue 1Y (TTM)209.14%
Revenue growth 3Y128.24%
Revenue growth 5Y-18.97%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, VSTM will show a very strong growth in Earnings Per Share. The EPS will grow by 21.92% on average per year.
  • VSTM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 81.07% yearly.
EPS Next Y41.93%
EPS Next 2Y29.43%
EPS Next 3Y30.46%
EPS Next 5Y21.92%
Revenue Next Year280.05%
Revenue Next 2Y155.85%
Revenue Next 3Y112.31%
Revenue Next 5Y81.07%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VSTM Yearly Revenue VS EstimatesVSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
VSTM Yearly EPS VS EstimatesVSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. VSTM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VSTM. In the last year negative earnings were reported.
  • Also next year VSTM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTM Price Earnings VS Forward Price EarningsVSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTM Per share dataVSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VSTM's earnings are expected to grow with 30.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.43%
EPS Next 3Y30.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VSTM Dividend Analysis

5.1 Amount

  • No dividends for VSTM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VSTM Fundamentals: All Metrics, Ratios and Statistics

VERASTEM INC

NASDAQ:VSTM (4/2/2026, 8:00:47 PM)

After market: 5.61 -0.02 (-0.36%)

5.63

+0.08 (+1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)05-11
Inst Owners95.27%
Inst Owner Change0%
Ins Owners0.66%
Ins Owner Change1.23%
Market Cap494.54M
Revenue(TTM)30.91M
Net Income(TTM)-209.47M
Analysts85.33
Price Target17.63 (213.14%)
Short Float %21.24%
Short Ratio9.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-49.21%
Min EPS beat(2)-108.2%
Max EPS beat(2)9.78%
EPS beat(4)2
Avg EPS beat(4)-14.72%
Min EPS beat(4)-108.2%
Max EPS beat(4)48.42%
EPS beat(8)4
Avg EPS beat(8)-6.99%
EPS beat(12)6
Avg EPS beat(12)-10.57%
EPS beat(16)8
Avg EPS beat(16)-5.87%
Revenue beat(2)2
Avg Revenue beat(2)49.3%
Min Revenue beat(2)3.86%
Max Revenue beat(2)94.73%
Revenue beat(4)3
Avg Revenue beat(4)21.35%
Min Revenue beat(4)-100%
Max Revenue beat(4)94.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.97%
PT rev (3m)8.04%
EPS NQ rev (1m)5.42%
EPS NQ rev (3m)18.25%
EPS NY rev (1m)0%
EPS NY rev (3m)7.69%
Revenue NQ rev (1m)7.83%
Revenue NQ rev (3m)29.6%
Revenue NY rev (1m)8.04%
Revenue NY rev (3m)9.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16
P/FCF N/A
P/OCF N/A
P/B 8.65
P/tB 12.13
EV/EBITDA N/A
EPS(TTM)-3.03
EYN/A
EPS(NY)-1.76
Fwd EYN/A
FCF(TTM)-1.68
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS0.35
BVpS0.65
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -85%
ROE -366.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.86%
FCFM N/A
ROA(3y)-90.67%
ROA(5y)-83.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y5.71%
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1321.98%
Cap/Sales 31.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 3.07
Altman-Z -6.47
F-Score6
WACC9.53%
ROIC/WACCN/A
Cap/Depr(3y)476.56%
Cap/Depr(5y)304.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.41%
EPS Next Y41.93%
EPS Next 2Y29.43%
EPS Next 3Y30.46%
EPS Next 5Y21.92%
Revenue 1Y (TTM)209.14%
Revenue growth 3Y128.24%
Revenue growth 5Y-18.97%
Sales Q2Q%N/A
Revenue Next Year280.05%
Revenue Next 2Y155.85%
Revenue Next 3Y112.31%
Revenue Next 5Y81.07%
EBIT growth 1Y-47.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y45.93%
EBIT Next 5Y14.17%
FCF growth 1Y-40.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.25%
OCF growth 3YN/A
OCF growth 5YN/A

VERASTEM INC / VSTM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VERASTEM INC?

ChartMill assigns a fundamental rating of 2 / 10 to VSTM.


Can you provide the valuation status for VERASTEM INC?

ChartMill assigns a valuation rating of 1 / 10 to VERASTEM INC (VSTM). This can be considered as Overvalued.


How profitable is VERASTEM INC (VSTM) stock?

VERASTEM INC (VSTM) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for VSTM stock?

The Earnings per Share (EPS) of VERASTEM INC (VSTM) is expected to grow by 41.93% in the next year.